Endostar (recombinant human endostatin injection)

DRUG2 trials

Sponsors

Yong Chen, Zhejiang Cancer Hospital

Conditions

Nasopharyngeal Cancinoma (NPC)Other Disorders of Soft Tissues

Phase 2

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Yong ChenOther Disorders of Soft Tissues

Start: 2020-09-01End: 2023-08-31Target: 210Updated: 2021-01-07

Platinum-Free Regimen in Nasopharyngeal Carcinoma

Not yet recruitingNCT07794488

Zhejiang Cancer HospitalNasopharyngeal Cancinoma (NPC)

Start: 2026-09-01End: 2030-12-30Target: 145Updated: 2026-08-31